Supreme Court Upholds Access to Abortion Pill Mifepristone, Ruling Unanimously

The United States Supreme Court has unanimously ruled to preserve broad access to mifepristone, the most widely used abortion pill, thwarting efforts to impose significant restrictions on its availability. This landmark decision by the nation's highest court dismisses a lower court's attempt to limit access to the crucial medication, thereby preventing a potentially drastic alteration to abortion access in the U.S. The ruling underscores the federal government's authority in regulating medications and comes as a significant victory for reproductive rights advocates and healthcare providers who had expressed grave concerns about potential limitations. The case, *FDA v. Alliance for Hippocratic Medicine*, challenged the FDA's over two-decade-old approval of mifepristone. The court's unanimous decision avoids a complex legal battle and reaffirms the established regulatory framework for mifepristone, offering stability in reproductive healthcare following the overturning of Roe v. Wade.